BARCELONA, Spain — The risk for mortality in chronic obstructive pulmonary disease (COPD) patients being treated with tiotropium is the same whether the drug is delivered by the Respimat Soft Mist ...

LONDON, Sept 8 (Reuters) - A major study on the safety of a mist inhaler used to treat chronic lung disease has found it does not increase the risk of patients dying early, in contrast to an earlier ...

Although tiotropium delivered as a dry powder has been widely used for chronic obstructive pulmonary disease (COPD) without major safety concerns since 2002, questions have been raised about the ...

A few months after the FDA cleared digital health company Propeller Health’ first collaboration with Boehringer Ingelheim to use its remote monitoring platform with BI’s Respimat inhaler, the FDA has ...

Boehringer Ingelheim is close to getting a licence for its chronic obstructive pulmonary disease blockbuster Spiriva as a treatment for asthma. Boehringer Ingelheim is close to getting a licence for ...

Boehringer Ingelheim announced results from the OTIVACTO study, an observational European real-world study of 7,443 Chronic Obstructive Pulmonary Disease (COPD ...

Spiolto® Respimat® is built on tiotropium, the active ingredient in Spiriva®, enhanced by olodaterol Spiolto® Respimat® provides significant improvements in lung function, COPD symptoms, quality of ...

It also showed high patient satisfaction with the Respimat ® device, both for inhaling and handling." Intended audiences: This press release is issued from our Corporate Headquarters in Ingelheim, ...

Boehringer Ingelheim announced new data from a Phase 3b study of Stiolto Respimat (tiotropium, olodaterol) in which treatment with Stiolto Respimat led to significant improvements in SGRQ total score ...

SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...

Data presented at European Respiratory Society International Congress 20181 In addition, the general condition of the patients was evaluated by the treating physician using the 8-point Physician’s ...